Mortality_in_a_cohort_of_long-term_users_of_hormone_replacement_therapy:_an_updated_analysis._OBJECTIVE--To_reexamine_the_mortality_experience_of_a_cohort_of_long-term_users_of_hormone_replacement_therapy_(HRT)_in_comparison_with_that_reported_previously_for_the_same_cohort_of_women,_paying_particular_attention_to_cardiovascular_mortality,_deaths_from_breast_and_endometrial_cancer,_and_deaths_attributed_to_suicide_or_suspected_suicide._DESIGN--Longitudinal_cohort_of_4544_long-term_users_of_HRT_amongst_whom_mortality_is_being_monitored_prospectively_in_comparison_with_expected_rates_in_the_female_population_of_England_and_Wales_(taking_account_of_age_and_calendar_period)._SUBJECTS--4544_women,_all_of_whom_were_recruited_from_specialist_menopause_clinics_around_Britain_and_had_taken_at_least_one_year's_continuous_HRT_at_the_time_of_recruitment_to_the_study._MAIN_OUTCOME_MEASURES--All_cause_mortality,_cardiovascular_mortality,_deaths_from_female_cancers,_deaths_attributed_to_suicide_or_suspected_suicide._RESULTS--Overall_mortality_(based_on_236_deaths_over_the_entire_study_period_from_recruitment_to_December_1988)_remained_significantly_lower_than_expected_on_the_basis_of_national_rates_(relative_risk_(RR)_0.56,_95%_confidence_limits_(CL)_0.47-0.66)._When_specific_causes_were_considered,_the_only_mortality_ratios_greater_than_unity_were_for_injury,_poisoning_and_violence_(1.54,_95%_CL_1.02-2.06),_and_for_suicide_and_suspected_suicide_('suicide')_(2.40,_95%_CL_1.68-3.11)._Comparison_of_the_ratios_for_the_112_additional_deaths_with_those_obtained_in_our_previous_analysis_revealed_that_one_of_the_few_ratios_to_show_any_increase_was_that_for_breast_cancer_mortality._This_rose_from_a_significant_deficit_of_0.55_(95%_CL_0.28-0.96)_in_the_earlier_period_to_1.00_(95%_CL_0.55-1.45)_in_the_later_period._There_was_also_a_suggestion_of_an_increase_in_breast_cancer_risk_with_increasing_duration_since_first_use_of_HRT._Most_of_the_other_cause-specific_ratios_were_very_similar_over_the_two_periods._The_ratio_of_death_from_all_circulatory_diseases_was_notably_lower_in_the_later_analysis_(RR_0.37,_95%_CL_0.15-0.58)_than_in_the_earlier_analysis_(0.51,_95%_CL_0.36-0.69),_as_were_all_of_the_subcategories_of_cardiovascular_death._The_mortality_ratio_for_cancer_of_the_ovary_and_uterine_adnexa_fell_from_1.12_in_the_previous_analysis_to_0.63_(95%_CL_0-1.41)._The_mortality_ratio_for_'suicide'_also_decreased,_but_was_only_slightly_lower_in_the_later_period._As_before,_however,_there_was_evidence_of_a_relatively_high_prevalence_of_prior_psychiatric_problems_amongst_the_recent_'suicide'_deaths,_suggesting_that_the_excess_of_deaths_from_'suicide'_may_be_a_manifestation_of_selection._CONCLUSION--These_data_are_consistent_with_a_beneficial_effect_of_HRT_on_cardiovascular_diseases,_although_updated_information_comparing_progestogen-opposed_and_-unopposed_treatment_is_not_available._The_increase_in_breast_cancer_mortality_contrasts_with_the_pattern_for_all_other_specific_causes_examined;_taken_together_with_the_suggestion_of_an_increase_in_breast_cancer_mortality_with_increasing_interval_since_first_exposure_to_HRT,_this_finding_is_somewhat_worrying.